| Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study F Moriarty, C Hardy, K Bennett, SM Smith, T Fahey BMJ open 5 (9), e008656, 2015 | 292 | 2015 |
| Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study T Pérez, F Moriarty, E Wallace, R McDowell, P Redmond, T Fahey bmj 363, 2018 | 151 | 2018 |
| Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA) R Galvin, F Moriarty, G Cousins, C Cahir, N Motterlini, M Bradley, ... European journal of clinical pharmacology 70 (5), 599-606, 2014 | 150 | 2014 |
| Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community‐dwelling older people: a prospective cohort study F Moriarty, K Bennett, C Cahir, RA Kenny, T Fahey British journal of clinical pharmacology 82 (3), 849-857, 2016 | 90 | 2016 |
| Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people F Moriarty, K Bennett, T Fahey, RA Kenny, C Cahir European journal of clinical pharmacology 71 (4), 473-482, 2015 | 88 | 2015 |
| Potentially inappropriate prescribing and vulnerability and hospitalization in older community-dwelling patients C Cahir, F Moriarty, C Teljeur, T Fahey, K Bennett Annals of Pharmacotherapy 48 (12), 1546-1554, 2014 | 85 | 2014 |
| A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms E Reeve, F Moriarty, R Nahas, JP Turner, L Kouladjian O’Donnell, ... Expert opinion on drug safety 17 (1), 39-49, 2018 | 71 | 2018 |
| ‘More of an art than a science’? The development, design and mechanics of the Delphi Technique S Drumm, C Bradley, F Moriarty Research in Social and Administrative Pharmacy 18 (1), 2230-2236, 2022 | 70 | 2022 |
| Deprescribing: future directions for research W Thompson, E Reeve, F Moriarty, M Maclure, J Turner, MA Steinman, ... Research in Social and Administrative Pharmacy 15 (6), 801-805, 2019 | 69 | 2019 |
| Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot C McCarthy, B Clyne, D Corrigan, F Boland, E Wallace, F Moriarty, ... Implementation Science 12, 1-13, 2017 | 52 | 2017 |
| Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis JK Ho, F Moriarty, JJ Manly, EB Larson, DA Evans, KB Rajan, EM Hudak, ... Hypertension 78 (3), 629-643, 2021 | 49 | 2021 |
| Research methods from human-centered design: Potential applications in pharmacy and health services research M Flood, M Ennis, A Ludlow, FF Sweeney, A Holton, S Morgan, C Clarke, ... Research in Social and Administrative Pharmacy 17 (12), 2036-2043, 2021 | 48 | 2021 |
| Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria JA Cooper, F Moriarty, C Ryan, SM Smith, K Bennett, T Fahey, E Wallace, ... European journal of clinical pharmacology 72 (5), 583-591, 2016 | 47 | 2016 |
| Fixed-dose combination antihypertensives and risk of medication errors F Moriarty, K Bennett, T Fahey Heart 105 (3), 204-209, 2019 | 46 | 2019 |
| Characterizing potentially inappropriate prescribing of proton pump inhibitors in older people in primary care in Ireland from 1997 to 2012 F Moriarty, K Bennett, C Cahir, T Fahey Journal of the American Geriatrics Society 64 (12), e291-e296, 2016 | 46 | 2016 |
| Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study K Cardwell, SM Smith, B Clyne, L McCullagh, E Wallace, C Kirke, T Fahey, ... BMJ open 10 (6), e035087, 2020 | 45 | 2020 |
| Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models F Moriarty, C Cahir, K Bennett, T Fahey BMJ Open 9 (1), e021832, 2019 | 43 | 2019 |
| GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster … C McCarthy, B Clyne, F Boland, F Moriarty, M Flood, E Wallace, SM Smith, ... PLoS medicine 19 (1), e1003862, 2022 | 39 | 2022 |
| Deprescribing guidelines: An international symposium on development, implementation, research and health professional education B Farrell, J Conklin, L Dolovich, H Irving, M Maclure, L McCarthy, ... Research in Social and Administrative Pharmacy 15 (6), 780-789, 2019 | 39 | 2019 |
| PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique E Barry, K O'Brien, F Moriarty, J Cooper, P Redmond, CM Hughes, ... BMJ open 6 (9), e012079, 2016 | 37 | 2016 |
